NHS Logo
  • Home
  • About Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter
  • Contact Us

Stories by Jessica Brand

Event Women in Academic Medicine Inaugural Meeting

Event Women in Academic Medicine Inaugural Meeting

Published on 29th March 2021
InnovationPartnershipTherapeutic Understanding the ‘why’ for trial participation drop out

InnovationPartnershipTherapeutic Understanding the ‘why’ for trial participation drop out

Published on 24th March 2021
InnovationPartnershipPrevention Cancer leading cause of death in those with diabetes

InnovationPartnershipPrevention Cancer leading cause of death in those with diabetes

Published on 5th February 2021
DiagnosticInnovation Serum keratin-18 as a biomarker to identify alcoholic hepatitis

DiagnosticInnovation Serum keratin-18 as a biomarker to identify alcoholic hepatitis

Published on 4th February 2021
DiagnosticInnovationPrevention Potential new biomarkers for detecting risk of small-for-gestational-age births

DiagnosticInnovationPrevention Potential new biomarkers for detecting risk of small-for-gestational-age births

Published on 12th January 2021
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Prevention Research participation opportunity- COVCHIM02 – COVID-19 Challenge Study
  • Prevention Enhancing Dementia Care Through Innovative Home Monitoring Initiative
  • Partnership New Era Begins: Imperial Launches Schools of Convergence Science
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre